| Which way is Phorm facing? When it "lost" its last four board members including the Chairman, the spin was that this would assist in a UKcentric approach.
Now the UK based CEO CFO has disappeared, along with some of the UK based legal team.
Which way are Phorm facing now?
I note also that there is no warm statement from the departing CFO.
The markets do not appear to be convinced by the Phorm spin on the recent board changes, nor the optimistic comments about the successful completion of the BT trials.
The lack of any clear public independent statement from BT themselves is also ominous. They have reportedly commented on their intranet, but the same press officer who made the intranet comments (Adam Liversage) was reportedly unwell, and unable to comment to the press. ?? Do BT not have a deputy press officer?
We have seen Phorm statements before that have spoken for their partners, and then have had to be corrected, when those partners issued retractions, clarifications or corrections to the over-enthusiastic Phorm spin.
Ertugrul's second statement seems a tad less upbeat about the progress made with the trials than his earlier one a few days ago. Maybe someone from BT rang him up and asked for a bit more caution in his choice of wording? |
